Evaluation of Daa (Direct-Acting Antiviral) Access Across the United States- The Interplay Between Hepatitis C Patient and Insurance Type
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1194
https://www.valueinhealthjournal.com/article/S1098-3015(16)01262-6/fulltext
Section Title :
Infection - Health Care Use & Policy Studies
Section Order :
759
First Page :
A222
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01262-6&doi=10.1016/j.jval.2016.03.1194